Dimensional Fund Advisors LP Adverum Biotechnologies, Inc. Transaction History

Dimensional Fund Advisors LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	SELL	$0.75 - $1.26 $77,906 - $130,882	-103,875 Reduced 35.52%	188,595 $141,000
Q3 2023 Nov 09, 2023	BUY	$1.5 - $2.33 $162,522 - $252,450	108,348 Added 58.85%	292,470 $438,000
Q2 2023 Aug 09, 2023	SELL	$0.68 - $1.59 $16 - $38	-24 Reduced 0.01%	184,122 $292,000
Q1 2023 May 12, 2023	SELL	$0.62 - $0.85 $10,433 - $14,303	-16,828 Reduced 8.37%	184,146 $132,000
Q4 2022 Feb 09, 2023	SELL	$0.54 - $10.3 $40,572 - $773,890	-75,135 Reduced 27.21%	200,974 $116,000
Q3 2022 Nov 10, 2022	SELL	$0.96 - $9.68 $45,155 - $455,318	-47,037 Reduced 14.56%	276,109 $262,000
Q2 2022 Aug 12, 2022	SELL	$0.81 - $1.34 $219,083 - $362,433	-270,473 Reduced 45.56%	323,146 $387,000
Q1 2022 May 13, 2022	SELL	$1.23 - $1.95 $115,018 - $182,346	-93,511 Reduced 13.61%	593,619 $778,000
Q4 2021 Feb 09, 2022	SELL	$1.74 - $2.4 $104,746 - $144,477	-60,199 Reduced 8.06%	687,130 $1.21 Million
Q3 2021 Nov 12, 2021	SELL	$2.08 - $3.6 $1.11 Million - $1.92 Million	-532,481 Reduced 41.61%	747,329 $1.62 Million
Q2 2021 Aug 12, 2021	SELL	$3.36 - $10.56 $398,590 - $1.25 Million	-118,628 Reduced 8.48%	1,279,810 $4.48 Million
Q1 2021 May 14, 2021	SELL	$9.26 - $14.36 $2.88 Million - $4.47 Million	-311,301 Reduced 18.21%	1,398,438 $13.8 Million
Q4 2020 Feb 25, 2021	BUY	$9.84 - $14.26 $16.8 Million - $24.4 Million	1,709,739 New	1,709,739 $18.5 Million

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.